SciELO - Scientific Electronic Library Online

 
vol.29 issue4Intensive nutritional support improves the nutritional status and body composition in severely malnourished children with cerebral palsyBreastfeeding and cognitive development: interference evaluation by "5 digits test" author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Nutrición Hospitalaria

On-line version ISSN 1699-5198Print version ISSN 0212-1611

Abstract

GIRALDO VILLA, Adriana  and  HOSPITAL PABLO TOBON URIBE. Grupo de Soporte Nutricional Pediátrico et al. Use of fish oil lipid emulsions in hospitalized patients under 18 years old with abnormal results in liver tests associated with total parental nutrition. Nutr. Hosp. [online]. 2014, vol.29, n.4, pp.844-851. ISSN 1699-5198.  http://dx.doi.org/10.3305/nh.2014.29.4.7209.

Introduction: Prolonged Total Parental Nutrition (TPN) is associated with life-threatening complications in the pediatric population, being cholestasis one of the most important ones. The source of fatty acids, the amount of phytosterols and the dose of lipids in the nutritional support, have been linked to the development of this complication. Purpose: To describe the behavior of liver function tests in pediatric patients with TPN where lipid based omega 3 fatty acids (Omegaven®) were used. Methods: A retrospective research was made in a population of children under 18 years old where omega 3 fatty acids were used for a minimum of 8 days. Patients were initially classified into two groups: cholestasis and abnormal liver tests. Levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TB), direct bilirubin (DB) gamma glutamyl transferase (GGT) and alkaline phosphatase (AP) before and after treatment with Omegaven® was evaluated. Results: 33 patients met the inclusion criteria. At the end of treatment with Omegaven®, 82.4% of patients who initially presented cholestasis showed resolution or improvement. The group of patients with abnormal liver tests 18.8% progressed to cholestasis. Conclusions: Our study suggests that the use of Omegaven® in pediatric patients with TPN and DB > 2 mg/dL, seem to reverse or improve cholestasis while in patients with abnormal liver tests we still don't have clear effect.

Keywords : Cholestasis; Lipids; Omega 3 fatty acids; Parenteral nutrition; Fish oils; Liver disease.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License